Marshall Wace’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-453,992
| Closed | -$4.59M | – | 3185 |
|
|
2022
Q4 | $4.59M | Hold |
453,992
| – | – | 0.01% | 1058 |
|
|
2022
Q3 | $4.5M | Buy |
453,992
+16,901
| +4% | +$168K | 0.01% | 1234 |
|
|
2022
Q2 | $4.27M | Hold |
437,091
| – | – | 0.01% | 1276 |
|
|
2022
Q1 | $4.26M | Buy |
437,091
+23,378
| +6% | +$228K | 0.01% | 1306 |
|
|
2021
Q4 | $4.01M | Buy |
413,713
+87,961
| +27% | +$852K | 0.01% | 1320 |
|
|
2021
Q3 | $3.15M | Hold |
325,752
| – | – | 0.01% | 1017 |
|
|
2021
Q2 | $3.15M | Buy |
+325,752
| New | +$3.15M | 0.01% | 940 |
|